Jpmorgan Chase & CO Bausch Health Companies Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BHC
# of Institutions
265Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$336 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$256 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$217 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$188 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$152 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.51B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...